Thomas Guttuso Jr,, MD, Associate Professor of Neurology, is continuing his work studying gabapentin in countering morning sickness or hyperemesis gravidarum associated with earlier stages of pregnancy. He will be conducting the first randomized, double-blinded study of the commonly used anti-seizure agent in a clinical trial supported by a $1.3 million grant from the National Institutes of Health. Dr. Guttuso is the Principal Investigator on the award. In prior pilot work published in 2010, Dr. Guttuso, who also holds an appointment in the UB Dept. of Obstetrics and Gynecology, showed that gabapentin, a relatively safe agent with essentially no drug-drug interactions or risk of congenital birth defects, reduced nausea and vomiting in women suffering from hyperemesis gravidarum by 80-95 percent. For more information see http://www.buffalo.edu/news/releases/2014/06/025.html.
The UB Dept. of Neurology held its annual Michael E. Cohen, MD, Residents Research Day and Graduation Banquet on June 13, 2014. All graduating residents presented their research findings, while the PGY-3 level residents presented research plans. The Research Day was coordinated by Dr. Robert Zivadinov and his staff. Winners of the Research Day Awards were Rajesh Gupta, PGY4 and Chief Resident, and Karanbir Singh, PGY3. The day’s program is attached. 2014 Research Day Program
Graduating residents were Cynthia Shin Beatty, Ahmad Abokhamis, Mahmoud Al Masry, Supriya Kohli, and Rajesh Gupta. Graduating neurophysiology fellows were Alyssa Fiddler, Salomi Salins, and Novreen Shahdad, and neuroimaging fellow Maria Serviole Verde. The incoming neurology chief residents for 2014-15 are Nour Abdelhamid and Pooja Sofat.